GCT randomizes first patient into Phase III Women’s health study in Bulgaria
First two patients were screened last week and one already has been randomized to participate in a global multicentre study which is managed by GCT in Central-Eastern European region.
This study is aimed at preterm delivery prevention and we are very excited to be a part of it, helping to prevent the consequences for both infants and mothers.
Updated: December 22, 2016
Share this:
Permanent link: https://2022.gctrials.com/news/gct-randomizes-first-patient-into-phase-iii-womens-health-study-in-bulgaria/
